×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Poseida Therapeutics Inc. (PSTX) NASDAQ

$3.18 0.10 (3.08%)

Market Cap: $297.19M

As of 03/28/24 03:59 PM EDT. Market closed.

(PSTX)

Poseida Therapeutics Inc. (PSTX)
NASDAQ

$3.18
0.10 (3.08%)

Market Cap: $297.19M

As of 03/28/24 03:59 PM EDT. Market closed.

Add to Portfolio

poseida therapeutics, inc. is currently developing car-t and gene therapy products for cancer and orphan diseases. spinout of transposagen biopharmaceuticals early this year, poseida is also collaborating with j&j’s janssen to develop allogeneic car-t therapies against cancer. poseida boasts best-in-class genome engineering capabilities for effectively silencing target genes or inserting ... read more

poseida therapeutics, inc. is currently developing car-t and gene therapy products for cancer and orphan diseases. spinout of transposagen biopharmaceuticals early this year, poseida is also collaborating with j&j’s janssen to develop allogeneic car-t therapies against cancer. poseida boasts best-in-class genome engineering capabilities for effectively silencing target genes or inserting therapeutic genes and/or technologies. proprietary tools include piggybac™ dna modification system, nextgen™ crispr, xtn™ talen and footprint-free™ gene editing system, which are clean (synthetic and virus-free) and can be surgically precise. poseida aims to shuttle the first car-t and gene therapy product candidates into phase i clinical trials in early 2016. poseida is now hiring and searching for ambitious and motivated scientists desiring a fast-paced work environment with diverse research opportunities in the field of cellular and gene therapy. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Eric Ostertag
Full Time Employees
307
URL
Address
9390 Towne Centre Drive, Suite 200, California, San Diego, 92121.
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
CEO
Eric Ostertag
Full Time Employees
307
Address
9390 Towne Centre Drive, Suite 200, California, San Diego, 92121.
PRICE CHART FOR POSEIDA THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$3.07
Previous Close
$3.08
Days Range
$2.81 - $3.14
52 week range
$1.54 - $4.27
Volume
697,730
Avg. Volume (30 days)
952,537
Market Cap
$297.19M
Dividend Yield
-
P/E
(2.41)
Shares Outstanding
96,489,127
Open
$3.07
Previous Close
$3.08
Days Range
$2.81 - $3.14
52 week range
$1.54 - $4.27
Volume
697,730
Avg. Volume (30 days)
952,537
Market Cap
$297.19M
Dividend Yield
-
P/E
(2.41)
Shares Outstanding
96,489,127
FINANCIAL STATEMENTS FOR POSEIDA THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR POSEIDA THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Mylet JohannaChief Financial OfficerMar 01, 2024 Option Exercise$4.1318,09174,716246,283Mar 04, 2024, 05:29 PM
Gergen Mark JExecutive ChairmanFeb 01, 2024 Option Exercise$3.4147,162160,822685,448Feb 02, 2024, 08:51 PM
Warner BrentPresident, Gene TherapyMar 01, 2023 Option Exercise$5.3526,617142,401374,036Mar 02, 2023, 06:30 PM
Mylet JohannaChief Financial OfficerMar 01, 2023 Option Exercise$5.354,32323,128177,631Mar 02, 2023, 06:28 PM
LEONHARDT HARRY JGC & Chief Compliance OfficerMar 01, 2023 Option Exercise$5.354,32323,128144,203Mar 02, 2023, 06:26 PM
Ostertag EricDirectorFeb 01, 2023 Option Exercise$7.0011,77682,432827,320Feb 03, 2023, 04:19 PM
Gergen Mark JPresident and CEOFeb 01, 2023 Option Exercise$7.0031,819222,733330,314Feb 03, 2023, 04:16 PM
Malin Life Sciences Holdings Ltd10% OwnerAug 08, 2022 Buy$3.502,150,0007,525,00011,835,673Aug 10, 2022, 08:49 PM
Ostertag EricExecutive ChairmanAug 08, 2022 Buy$3.50142,857500,000838,824Aug 10, 2022, 06:13 PM
Ostertag EricExecutive ChairmanAug 03, 2022 Sale$3.69160,696592,8080Aug 05, 2022, 04:09 PM
Ingalls Kerry D.Chief Operating OfficerMar 16, 2022 Buy$3.983,00011,94055,000Mar 18, 2022, 08:01 PM
Mylet JohannaChief Financial OfficerDec 21, 2021 Option Exercise$1.595,7169,06134,231Dec 22, 2021, 04:53 PM
Spear Matthew A.Chief Medical OfficerDec 06, 2021 Option Exercise$1.3210,00013,22061,485Dec 08, 2021, 08:38 PM
Malin Life Sciences Holdings Ltd10% OwnerDec 06, 2021 Buy$6.901,82812,6139,685,673Dec 07, 2021, 06:03 AM
Malin Life Sciences Holdings Ltd10% OwnerDec 02, 2021 Buy$6.884,29629,5509,683,845Dec 02, 2021, 06:33 PM
Malin Life Sciences Holdings Ltd10% OwnerDec 01, 2021 Buy$6.8518,365125,8069,679,549Dec 02, 2021, 06:33 PM
Malin Life Sciences Holdings Ltd10% OwnerNov 30, 2021 Buy$6.8528,592195,8389,661,184Dec 02, 2021, 06:33 PM
Malin Life Sciences Holdings Ltd10% OwnerNov 29, 2021 Buy$6.8911,05776,2099,632,592Nov 29, 2021, 07:55 PM
Malin Life Sciences Holdings Ltd10% OwnerNov 26, 2021 Buy$6.8127,251185,4929,621,535Nov 29, 2021, 07:55 PM
Malin Life Sciences Holdings Ltd10% OwnerNov 24, 2021 Buy$6.891,0547,2609,594,284Nov 29, 2021, 07:55 PM
Malin Life Sciences Holdings Ltd10% OwnerNov 23, 2021 Buy$6.7714,62598,9899,593,230Nov 23, 2021, 06:41 PM
Malin Life Sciences Holdings Ltd10% OwnerNov 19, 2021 Buy$7.4411,10482,6509,578,605Nov 23, 2021, 06:41 PM
Ostertag EricChief Executive OfficerNov 19, 2021 Option Exercise$9.151,0009,150697,422Nov 22, 2021, 07:50 PM
Ingalls Kerry D.Chief Operating OfficerNov 17, 2021 Buy$7.002,00014,0002,000Nov 18, 2021, 09:12 PM
Malin Life Sciences Holdings Ltd10% OwnerNov 18, 2021 Buy$7.1871,312511,6859,567,501Nov 18, 2021, 08:24 PM
Malin Life Sciences Holdings Ltd10% OwnerNov 17, 2021 Buy$7.21280,3842,021,8219,496,189Nov 18, 2021, 08:24 PM
Malin Life Sciences Holdings Ltd10% OwnerNov 16, 2021 Buy$7.1727,680198,3839,215,805Nov 18, 2021, 08:24 PM
Ostertag EricChief Executive OfficerNov 08, 2021 Sale$7.0918,924134,1713,659,503Nov 10, 2021, 06:06 PM
Ostertag EricChief Executive OfficerOct 11, 2021 Option Exercise$9.1518,525169,504696,422Oct 13, 2021, 06:59 PM
Ostertag EricChief Executive OfficerOct 01, 2021 Sale$7.0220,029140,6043,669,376Oct 05, 2021, 06:16 PM
Ostertag EricChief Executive OfficerSep 20, 2021 Sale$8.0020,000160,020160,696Sep 22, 2021, 05:51 PM
Ostertag EricChief Executive OfficerSep 13, 2021 Option Exercise$8.1221,281172,729675,415Sep 15, 2021, 06:58 PM
Ostertag EricChief Executive OfficerSep 14, 2021 Sale$8.1420,000162,712180,696Sep 15, 2021, 06:58 PM
Spear Matthew A.Chief Medical OfficerSep 09, 2021 Option Exercise$1.3210,00013,22051,485Sep 10, 2021, 04:19 PM
Ostertag EricChief Executive OfficerSep 02, 2021 Sale$8.3461,262510,9253,679,826Sep 03, 2021, 04:54 PM
Ostertag EricChief Executive OfficerSep 01, 2021 Sale$8.4651,149432,7213,711,789Sep 03, 2021, 04:54 PM
Spear Matthew A.Chief Medical OfficerAug 20, 2021 Option Exercise$1.324,0005,28845,485Aug 24, 2021, 05:12 PM
Spear Matthew A.Chief Medical OfficerAug 20, 2021 Sale$8.794,00035,14241,485Aug 24, 2021, 05:12 PM
Ostertag EricChief Executive OfficerAug 06, 2021 Option Exercise$9.15111,1491,017,013654,134Aug 10, 2021, 06:56 PM
Ostertag EricChief Executive OfficerAug 03, 2021 Sale$7.9919,936159,2893,738,475Aug 04, 2021, 04:57 PM
Ostertag EricChief Executive OfficerAug 02, 2021 Sale$8.1313,737111,6823,748,876Aug 04, 2021, 04:57 PM
Spear Matthew A.Chief Medical OfficerJul 28, 2021 Option Exercise$1.3220,00026,44041,485Jul 30, 2021, 04:29 PM
Ostertag EricChief Executive OfficerJul 02, 2021 Sale$8.9127,542245,2743,770,309Jul 06, 2021, 05:35 PM
Ostertag EricChief Executive OfficerJul 01, 2021 Sale$9.7720,563200,9013,770,413Jul 06, 2021, 05:35 PM
Spear Matthew A.Chief Medical OfficerJun 17, 2021 Option Exercise$1.325,0006,61021,485Jun 21, 2021, 08:02 PM
Spear Matthew A.Chief Medical OfficerJun 11, 2021 Option Exercise$1.324,0005,28820,485Jun 14, 2021, 06:18 PM
Spear Matthew A.Chief Medical OfficerJun 11, 2021 Sale$9.444,00037,74716,485Jun 14, 2021, 06:18 PM
Ostertag EricChief Executive OfficerJun 02, 2021 Sale$8.3440,722339,6213,781,142Jun 03, 2021, 07:21 PM
Ostertag EricChief Executive OfficerJun 01, 2021 Sale$8.6141,194354,6803,802,388Jun 03, 2021, 07:21 PM
Ostertag EricChief Executive OfficerMay 04, 2021 Sale$8.4435,986303,7223,823,881May 05, 2021, 07:29 PM
Ostertag EricChief Executive OfficerMay 03, 2021 Sale$9.0118,326165,1173,842,656May 05, 2021, 07:29 PM
Spear Matthew A.Chief Medical OfficerApr 23, 2021 Option Exercise$1.325,0006,61016,485Apr 23, 2021, 08:49 PM
Spear Matthew A.Chief Medical OfficerApr 21, 2021 Option Exercise$1.324,0005,28815,485Apr 23, 2021, 08:49 PM
Spear Matthew A.Chief Medical OfficerApr 21, 2021 Sale$8.444,00033,75211,485Apr 23, 2021, 08:49 PM
Ostertag EricChief Executive OfficerApr 01, 2021 Sale$9.5557,181546,3303,882,383Apr 05, 2021, 07:50 PM
Ostertag EricChief Executive OfficerApr 05, 2021 Sale$9.6657,819558,6683,853,834Apr 05, 2021, 07:50 PM
Ostertag EricChief Executive OfficerMar 02, 2021 Sale$11.5457,060658,4153,912,217Mar 03, 2021, 07:38 PM
Ostertag EricChief Executive OfficerMar 01, 2021 Sale$11.6757,940676,0463,942,515Mar 03, 2021, 07:38 PM
Ostertag EricChief Executive OfficerFeb 23, 2021 Option Exercise$1.17111,395130,666542,985Feb 25, 2021, 07:01 PM
Ostertag EricChief Executive OfficerFeb 16, 2021 Sale$10.00133,1491,332,036200,696Feb 17, 2021, 05:28 PM
Ostertag EricChief Executive OfficerFeb 10, 2021 Option Exercise$1.2967,53487,119431,590Feb 12, 2021, 05:03 PM
Ostertag EricChief Executive OfficerFeb 10, 2021 Sale$10.0012,389123,890333,845Feb 12, 2021, 05:03 PM
Ostertag EricChief Executive OfficerJan 21, 2021 Sale$10.004,46244,620346,234Jan 25, 2021, 07:42 PM
Mylet JohannaSenior Vice President, FinanceJan 15, 2021 Option Exercise$0.304,7281,41826,813Jan 19, 2021, 05:00 PM
Spear Matthew A.Chief Medical OfficerJan 15, 2021 Option Exercise$1.327,56410,00011,485Jan 19, 2021, 05:00 PM
Spear Matthew A.Chief Medical OfficerJan 08, 2021 Option Exercise$1.323,9215,1843,921Jan 11, 2021, 05:00 PM
Murphy SeanDirectorJul 14, 2020 Buy$16.0010,000160,00010,000Jul 15, 2020, 05:00 PM
Hirsch DavidDirectorJul 14, 2020 Buy$16.00250,0004,000,0002,714,245Jul 15, 2020, 05:00 PM
Lloyd Marcea BlandDirectorJul 14, 2020 Buy$16.0010,000160,00010,000Jul 15, 2020, 05:00 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Mylet JohannaChief Financial Officer03/01/202474,716
Gergen Mark JExecutive Chairman02/01/2024160,822
Warner BrentPresident, Gene Therapy03/01/2023142,401
Mylet JohannaChief Financial Officer03/01/202323,128
LEONHARDT HARRY JGC & Chief Compliance Officer03/01/202323,128
Ostertag EricDirector02/01/202382,432
Gergen Mark JPresident and CEO02/01/2023222,733
Malin Life Sciences Holdings Ltd10% Owner08/08/20227,525,000
Ostertag EricExecutive Chairman08/08/2022500,000
Ostertag EricExecutive Chairman08/03/2022592,808
Ingalls Kerry D.Chief Operating Officer03/16/202211,940
Mylet JohannaChief Financial Officer12/21/20219,061
Spear Matthew A.Chief Medical Officer12/06/202113,220
Malin Life Sciences Holdings Ltd10% Owner12/06/202112,613
Malin Life Sciences Holdings Ltd10% Owner12/02/202129,550
Malin Life Sciences Holdings Ltd10% Owner12/01/2021125,806
Malin Life Sciences Holdings Ltd10% Owner11/30/2021195,838
Malin Life Sciences Holdings Ltd10% Owner11/29/202176,209
Malin Life Sciences Holdings Ltd10% Owner11/26/2021185,492
Malin Life Sciences Holdings Ltd10% Owner11/24/20217,260
Malin Life Sciences Holdings Ltd10% Owner11/23/202198,989
Malin Life Sciences Holdings Ltd10% Owner11/19/202182,650
Ostertag EricChief Executive Officer11/19/20219,150
Ingalls Kerry D.Chief Operating Officer11/17/202114,000
Malin Life Sciences Holdings Ltd10% Owner11/18/2021511,685
Malin Life Sciences Holdings Ltd10% Owner11/17/20212,021,821
Malin Life Sciences Holdings Ltd10% Owner11/16/2021198,383
Ostertag EricChief Executive Officer11/08/2021134,171
Ostertag EricChief Executive Officer10/11/2021169,504
Ostertag EricChief Executive Officer10/01/2021140,604
Ostertag EricChief Executive Officer09/20/2021160,020
Ostertag EricChief Executive Officer09/13/2021172,729
Ostertag EricChief Executive Officer09/14/2021162,712
Spear Matthew A.Chief Medical Officer09/09/202113,220
Ostertag EricChief Executive Officer09/02/2021510,925
Ostertag EricChief Executive Officer09/01/2021432,721
Spear Matthew A.Chief Medical Officer08/20/20215,288
Spear Matthew A.Chief Medical Officer08/20/202135,142
Ostertag EricChief Executive Officer08/06/20211,017,013
Ostertag EricChief Executive Officer08/03/2021159,289
Ostertag EricChief Executive Officer08/02/2021111,682
Spear Matthew A.Chief Medical Officer07/28/202126,440
Ostertag EricChief Executive Officer07/02/2021245,274
Ostertag EricChief Executive Officer07/01/2021200,901
Spear Matthew A.Chief Medical Officer06/17/20216,610
Spear Matthew A.Chief Medical Officer06/11/20215,288
Spear Matthew A.Chief Medical Officer06/11/202137,747
Ostertag EricChief Executive Officer06/02/2021339,621
Ostertag EricChief Executive Officer06/01/2021354,680
Ostertag EricChief Executive Officer05/04/2021303,722
Ostertag EricChief Executive Officer05/03/2021165,117
Spear Matthew A.Chief Medical Officer04/23/20216,610
Spear Matthew A.Chief Medical Officer04/21/20215,288
Spear Matthew A.Chief Medical Officer04/21/202133,752
Ostertag EricChief Executive Officer04/01/2021546,330
Ostertag EricChief Executive Officer04/05/2021558,668
Ostertag EricChief Executive Officer03/02/2021658,415
Ostertag EricChief Executive Officer03/01/2021676,046
Ostertag EricChief Executive Officer02/23/2021130,666
Ostertag EricChief Executive Officer02/16/20211,332,036
Ostertag EricChief Executive Officer02/10/202187,119
Ostertag EricChief Executive Officer02/10/2021123,890
Ostertag EricChief Executive Officer01/21/202144,620
Mylet JohannaSenior Vice President, Finance01/15/20211,418
Spear Matthew A.Chief Medical Officer01/15/202110,000
Spear Matthew A.Chief Medical Officer01/08/20215,184
Murphy SeanDirector07/14/2020160,000
Hirsch DavidDirector07/14/20204,000,000
Lloyd Marcea BlandDirector07/14/2020160,000
Load More Insider Transactions
FUNDS WITH A POSITION IN POSEIDA THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
PENTWATER CAPITAL MANAGEMENT LP5,975,0000.23%No changeEvent Driven
BLACKROCK INC.5,031,1730.00043%-0.43%Other
GEODE CAPITAL MANAGEMENT, LLC1,523,0550.00054%7.38%Other
RENAISSANCE TECHNOLOGIES LLC530,1000.00276%-32.3%Other
AQR CAPITAL MANAGEMENT LLC23,6400.00015%-72.82%Other
CHANGE IN SHARES OUTSTANDING FOR POSEIDA THERAPEUTICS INC
STOCK BUYBACKS FOR POSEIDA THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
4.22%
1Q
12/31/2023
06/30/2023
10.35%
2Q
12/31/2023
03/31/2023
11.02%
3Q
12/31/2023
12/31/2022
11.23%
4Q
12/31/2023
09/30/2022
24.89%
5Q
12/31/2023
06/30/2022
52.72%
6Q
12/31/2023
03/31/2022
53.10%
7Q
12/31/2023
12/31/2021
53.21%
8Q
12/31/2023
09/30/2021
53.74%
9Q
12/31/2023
06/30/2021
54.10%
10Q
12/31/2023
03/31/2021
54.52%
11Q
12/31/2023
09/30/2020
74.22%
13Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
4.22%
1Q
06/30/2023
10.35%
2Q
03/31/2023
11.02%
3Q
12/31/2022
11.23%
4Q
09/30/2022
24.89%
5Q
06/30/2022
52.72%
6Q
03/31/2022
53.10%
7Q
12/31/2021
53.21%
8Q
09/30/2021
53.74%
9Q
06/30/2021
54.10%
10Q
03/31/2021
54.52%
11Q
09/30/2020
74.22%
13Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR POSEIDA THERAPEUTICS INC
LOADING...